Evento

Asymmetric dimethylarginine (adma) inhibits the effect of erythropoietin on endothelial cell migration in a proinflammatory environment

Chamorro, María Eugenia Icon; Maltaneri, Romina Eugenia Icon; Schiappacasse, Agustina Icon; Vittori, Daniela Cecilia Icon; Nesse, Alcira Beatriz Icon

Otros responsables

Fecha

2019

Editorial

Fundación Revista Medicina

Revista

Título del libro

Nombre del evento

LXIV Reunión Anual de la Sociedad Argentina de Investigación Clínica; LI Reunión Anual de la Asociación Argentina de Farmacología Experimental; XXI Reunión Anual de la Sociedad Argentina de Biología; XXXI Reunión Anual de la Sociedad Argentina de Protozoología; IX Reunión Anual de la Asociación Argentina de Nanomedicinas y VI Reunión Científica Regional de la Asociación Argentina de Ciencia y Tecnología de Animales de Laboratorio

Fecha del evento

2019-11-13

Institución organizadora

Sociedad Argentina de Investigación Clínica
Asociación Argentina de Farmacología Experimenta
Sociedad Argentina de Biología
Sociedad Argentina de Protozoología
Asociación Argentina de Ciencia y Tecnología de Animales de Laboratorio
Asociación Argentina de Nanomedicinas

ISSN

eISSN

ISBN

Idioma

Inglés

Tipo del evento

Reunión

Clasificación temática

Resumen

Hyperhomocysteinemia induces vascular endothelial dysfunction, an early hallmark of atherogenesis. Previously, we found a sensitizing effect of the inflammatory cytokine TNF-alpha on a promigratory action of erythropoietin (Epo), which was not observed when the molecule was modified by N-homocysteinylation with homocysteine thiolactone, the reactive derivative of homocysteine. The strong correlation found between hyperhomocysteinemia and levels of asymmetric dimethylarginine (ADMA), the amino acid formed during methylation of proteins, has been considered of interest in endothelial dysfunction. Therefore, the aim of this work was to study whether ADMA accumulation could affect the ability of different factors to induce endothelial cell migration. Wound healing assays of EA.hy926 endothelial cells stimulated by 10% fetal bovine serum (FBS), 20 ng/mL VEGF or Epo+TNF-alpha (80 ng/mL and 30 ng/mL, respectively) were performed in the presence or absence of ADMA (30 or 100 µM). Results are expressed as a percentage of the cell migration obtained in the presence of FBS. FBS: 100; Control: 22.0±2.4; ADMA: 20.1±3.4; *FBS+ADMA30: 66.6±3.5; **FBS+ADMA100: 43.3±3.9; Epo+TNF-alpha: 56.4±1.2; *Epo+TNF-alpha+ADMA30: 37.4±2.9; **Epo+TNF-alpha+ADMA100: 31.1±1.6; VEGF: 44.5±2.9; *VEGF+ADMA30: 30.3±2.1; **VEGF+ADMA100: 19.6±2.8; *P<0.05 and **P<0.01 vs. respective controls, n=4. It can be seen that the inhibition of the promigratory effects of all the factors analyzed was dependent on ADMA concentration. The results of cell viability and MTT assays confirmed that the effects of ADMA on the promigratory action of Epo+TNF-alpha and VEGF cannot be attributed to cytotoxicity or cell proliferation. These results underline the important role of homocysteine in cardiovascular pathophysiology, since increased homocysteine is involved in a direct inhibition of the enzymes responsible for ADMA degradation.

Aprobación

Revisión

Complementado por

Referenciado por

Licencia Creative Commons

Excepto donde se indique lo contrario, la licencia de este ítem se describe como by-nc-sa